MoneyWorks4Me

FDC - Quaterly Results

06 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 5051.04 millions, up 5.30% as compared to Rs. 4796.98 millions during the corresponding quarter last year.Profit for the quarter ended September 2024 grew by 2.68% to Rs. 739.73 millions from Rs. 720.41 millions.Operating Profit saw a handsome growth to 1070.78 millions from 1060.95 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 5051.04 4796.98 5.30 11292.45 10097.38 11.84 19161.87 17770.32 7.83
Other Income 346.78 273.85 26.63 628.31 571.69 9.90 1032.16 539.12 91.45
PBIDT 1070.78 1060.95 0.93 2769.24 2558.85 8.22 4416.74 3084.87 43.17
Interest 10.71 10.51 1.90 23.63 20.89 13.12 40.00 40.39 -0.97
PBDT 1060.07 1050.44 0.92 2745.61 2537.96 8.18 4376.74 3044.48 43.76
Depreciation 137.58 98.13 40.20 247.53 194.01 27.59 397.29 387.58 2.51
PBT 922.49 952.31 -3.13 2498.08 2343.95 6.58 3979.45 2656.90 49.78
TAX 182.76 231.90 -21.19 608.46 538.03 13.09 907.82 647.25 40.26
Deferred Tax -17.24 16.71 -203.17 48.46 17.84 171.64 51.63 -42.75 -220.77
PAT 739.73 720.41 2.68 1889.62 1805.92 4.63 3071.63 2009.65 52.84
Equity 162.81 162.81 0.00 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 21.20 22.12 -4.15 24.52 25.34 -3.23 23.05 17.36 32.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..